2022
Telehealth Reduces Missed Appointments in Pediatric Patients with Tuberculosis Infection
Zhao A, Butala N, Luc CM, Feinn R, Murray TS. Telehealth Reduces Missed Appointments in Pediatric Patients with Tuberculosis Infection. Tropical Medicine And Infectious Disease 2022, 7: 26. PMID: 35202221, PMCID: PMC8877294, DOI: 10.3390/tropicalmed7020026.Peer-Reviewed Original ResearchTuberculosis infectionPediatric patientsAppointment ratesActive TB diseaseLatent tuberculosis infectionRetrospective chart reviewRisk of progressionPoor treatment adherenceChi-square testTB diseaseChart reviewTuberculosis clinicClinical variablesTreatment adherenceMissed appointmentsPatientsSecond cohortSecondary aimPrimary providersClinicTelehealthCOVID-19 pandemicTherapyHigh rateInfectionBacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers
Harris JC, Collins MS, Huang PH, Schramm CM, Nero T, Yan J, Murray TS. Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers. Microbiology Spectrum 2022, 10: e02535-21. PMID: 35107362, PMCID: PMC8809330, DOI: 10.1128/spectrum.02535-21.Peer-Reviewed Original ResearchConceptsAlbuterol nebulizationNebulized therapyHome nebulizersCystic fibrosisChronic respiratory diseasesAerosolized medicationsLung infectionCF patientsRespiratory diseasePathogenic bacteriaPatientsNext Generation ImpactorClinical isolatesMedicationsLungPari LCTherapyAnonymous patientsClinical bacteriaNebulizationNebulizerAerosolizationPathogenic microbesDetachmentSubset of bacteria
2018
Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output
Collins MS, O'Brien M, Schramm CM, Murray TS. Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output. Journal Of Cystic Fibrosis 2018, 18: 233-235. PMID: 30224332, DOI: 10.1016/j.jcf.2018.08.005.Peer-Reviewed Original Research
2016
Sinus Disease in Cystic Fibrosis
Collins M, Murray T, Rizzi M. Sinus Disease in Cystic Fibrosis. 2016, 121-133. DOI: 10.1007/978-3-319-21744-4_9.Peer-Reviewed Original ResearchSinus diseaseCystic fibrosisSurgical interventionMulti-drug resistant organismsAggressive medical managementOtolaryngology referralRefractory diseaseCommon indicationMedical managementNasal polypsPatient outcomesSurgical techniqueCommon inherited diseaseResistant organismsDiseaseJudicious usePatientsInherited diseaseFibrosisInterventionSurgeryReferralPolypsCaucasians
2015
Baby bottle steam sterilizers for disinfecting home nebulizers inoculated with non-tuberculous mycobacteria
Towle D, Callan DA, Lamprea C, Murray TS. Baby bottle steam sterilizers for disinfecting home nebulizers inoculated with non-tuberculous mycobacteria. Journal Of Hospital Infection 2015, 92: 222-225. PMID: 26810616, DOI: 10.1016/j.jhin.2015.08.030.Peer-Reviewed Original Research
2013
Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LCMS/MS
Peaper DR, Kulkarni MV, Tichy AN, Jarvis M, Murray TS, Hodsdon ME. Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LCMS/MS. Bioanalysis 2013, 5: 147-157. PMID: 23330558, PMCID: PMC5753620, DOI: 10.4155/bio.12.310.Peer-Reviewed Original ResearchConceptsLife-threatening infectionsIll patientsGram-negative rodsDiagnostic testsExpression of carbapenemasesAvailable diagnostic testsRapid diagnostic testsRatios of metabolitesLC-MS/MSCarbapenemase activityHodge testCarbapenem resistanceCarbapenemase productionCarbapenem antibioticsΒ-lactam antibioticsThreshold cutoffDA increaseErtapenem hydrolysisLC-MS/MS methodPatientsClinical laboratoriesAntibioticsLCMS/MSInfectionPhysiological levels
2012
The Ability of Virulence Factor Expression by Pseudomonas aeruginosa to Predict Clinical Disease in Hospitalized Patients
Ledizet M, Murray TS, Puttagunta S, Slade MD, Quagliarello VJ, Kazmierczak BI. The Ability of Virulence Factor Expression by Pseudomonas aeruginosa to Predict Clinical Disease in Hospitalized Patients. PLOS ONE 2012, 7: e49578. PMID: 23152923, PMCID: PMC3495863, DOI: 10.1371/journal.pone.0049578.Peer-Reviewed Original ResearchConceptsP. aeruginosa infectionAeruginosa infectionBacterial factorsHospitalized patientsUrinary tractPositive P. aeruginosa culturesP. aeruginosaUrinary tract cathetersP. aeruginosa isolatesLogistic regression modelsPseudomonas aeruginosaProspective cohortDiabetes mellitusSubgroup analysisClinical dataTreatment decisionsClinical diseaseAeruginosa isolatesAnimal modelsPatientsClinical sitesFactor expressionInfectionHost factorsP. aeruginosa cultures
2011
Low Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates among Connecticut Veterans
Fink SL, Martinello RA, Campbell SM, Murray TS. Low Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates among Connecticut Veterans. Antimicrobial Agents And Chemotherapy 2011, 56: 582-583. PMID: 22064529, PMCID: PMC3256079, DOI: 10.1128/aac.05024-11.Peer-Reviewed Original ResearchConceptsHeterogeneous vancomycin-intermediate Staphylococcus aureusMethicillin-resistant Staphylococcus aureusHeterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesVancomycin-intermediate Staphylococcus aureusLow-prevalence populationsStaphylococcus aureus isolatesStaphylococcus aureusPrevalence populationsRoutine screeningVeterans HospitalLow prevalenceAureus isolatesCurve analysisResistance detectionAureusIsolatesPatientsHospitalPrevalenceEtest
2010
Lyme Disease
Murray TS, Shapiro ED. Lyme Disease. Clinics In Laboratory Medicine 2010, 30: 311-328. PMID: 20513553, PMCID: PMC3652387, DOI: 10.1016/j.cll.2010.01.003.Peer-Reviewed Original ResearchConceptsLyme diseaseClinical presentation variesOnly nonspecific symptomsCranial nerve palsyMultiple erythema migransSigns of infectionCommon vector-borne diseaseNerve palsyDisseminated diseaseMost patientsNonspecific symptomsErythema migransSerologic testingAppropriate antimicrobialsEarly diseasePresentation variesLate diseaseObjective signsSpirochete Borrelia burgdorferiDiseaseBorrelia burgdorferiPatientsMigransSymptomsInfection
2007
Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients
Murray TS, Egan M, Kazmierczak BI. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Current Opinion In Pediatrics 2007, 19: 83-88. PMID: 17224667, DOI: 10.1097/mop.0b013e3280123a5d.Peer-Reviewed Original ResearchConceptsCystic fibrosis patientsChronic colonizationAcute infectionFibrosis patientsCystic fibrosisP. aeruginosaChronic pulmonary colonizationChronic pulmonary diseaseCystic fibrosis airwayHost immune systemMucoid P. aeruginosaP. aeruginosa behaviorCystic fibrosis lungPulmonary diseaseClinical benefitChronic infectionP. aeruginosa pathogenesisLeading causePulmonary colonizationNew therapiesImmune systemAggressive usePotential therapeuticsInfectionPatients